Applied DNA Sciences to Begin Trading Under New Ticker ‘BNBX’ Reflecting Digital Asset Treasury Strategy
October 6th, 2025
News
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation
September 29th, 2025
Applied DNA Abstracts Selected for Poster Presentations Showcasing LineaDNA and LineaIVT Platforms at Upcoming mRNA and CAR T Industry Conferences
September 23rd, 2025
Applied DNA Reports Third Quarter Fiscal 2025 Financial Results
August 14th, 2025
Applied DNA Announces New Follow-On LineaDNA™ Order from Global IVD Manufacturer for Use in Cancer Diagnostic Application
July 24th, 2025
Applied DNA Regains Compliance with All Nasdaq Continued Listing Requirements
July 7th, 2025
Applied DNA Sharpens Strategic Focus on Synthetic DNA Manufacturing for Biotherapeutics Applications, Consolidates Operations Behind LineaRx
June 30th, 2025
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward
June 17th, 2025
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3’25 Financial Results Report in Mid-August
June 16th, 2025
